Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia: Letter
Anti-platelet factor 4-heparin antibodies present a major risk of heparin-induced thrombocytopenia (HIT). The use of intravenous immune globulin neutralized large amounts of these antibodies in a patient so that heparin could be used safely during emergency surgery.
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2018-05, Vol.378 (19), p.1845 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Anti-platelet factor 4-heparin antibodies present a major risk of heparin-induced thrombocytopenia (HIT). The use of intravenous immune globulin neutralized large amounts of these antibodies in a patient so that heparin could be used safely during emergency surgery. |
---|---|
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJMc1801799 |